XRP Adoption Expands to 6,000 US Pharmacies
NewsWellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.

- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.

The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Bitcoin Reportedly Falls Below $57,000 for First Time in Two Years
Bitcoin did not fall in isolation. The broader market declined sharply alongside it, with the Crypto Fear & Greed Index hitting 12 out of 100 , a reading labele...
Wealth Platforms Hit Record Bitcoin ETP Ownership: Report
That figure represents 40.5% of all 13F-reported spot Bitcoin ETP holdings and 11.2% of all bitcoin held across those funds, both series highs since spot Bitcoi...
CoinDesk Reports Lagarde’s Warning on Europe’s Tokenized-Asset Rules
The ECB launched its Pontes platform in September 2026 to enable settlement of tokenized securities in central bank money, providing a neutral backbone for digi...
Glassnode Cites Bitcoin Capitulation Near $62K
In a linked post , Glassnode said Bitcoin had crashed to $62K and that realized losses had reached levels seen only near past cycle lows.
Sky USDS Reportedly Shrinks 35% as $1.5B Leaves Reserves
The outflow hit Sky’s Peg Stability Module (PSM), the mechanism that allows users to swap USDS one-for-one with USDC.
1inch Reportedly Taps Hyperliquid for Perpetual Futures Trading
According to The Block’s report on the announcement, the integration routes positions through Hyperliquid’s on-chain order book.